This issue comprises two parts. The first part examines pharmacology of drug classes and effects on the sleep--wake processes. The second part focuses on therapeutics for various sleep disorders. In the first part, basic neuropharmacology of sleep-wake states is discussed. Other articles review hypnotics, allergy and cardiovascular drugs, anti-convulsant drugs, anti-depressant and anti-psychotic drugs, and stimulants. The second part focuses on pharmacology for specific sleep disorders: primary insomnia, co-morbid insomnia, sleep-related breathing disorders, narcolepsy and disorders of daytime sleepiness, movement disroders, parasomnias, and circadian rhythm disorders.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. CME Accreditation Page and Author Disclosure - p. 4 5. Forthcoming Issues - p. 5 6. Contributors - p. 6 7. Foreword - p. 7 8. Preface - p. 8 9. Part I: The Pharmacology of Drug Classes and Effects on Sleep-Wake Processes - p. 9 10. Neuropharmacology of Sleep and Wakefulness - p. 10 11. Pharmacotherapy for Insomnia - p. 24 12. Allergy/Respiratory and Cardiovascular Drugs - p. 34 13. Drug-Related Sleep Stage Changes: Functional Significance and Clinical Relevance - p. 41 14. Antidepressant and Antipsychotic Drugs - p. 47 15. Stimulants in Excessive Daytime Sleepiness - p. 62 16. Part II: Therapeutics for Various Sleep Disorders - p. 74 17. Pharmacologic Treatment of Primary Insomnia - p. 75 18. Comorbid Insomnia: Reciprocal Relationships and Medication Management - p. 90 19. Therapeutics for Sleep-disordered Breathing - p. 105 20. Therapeutics of Narcolepsy - p. 115 21. The Pharmacologic Management of Restless Legs Syndrome and Periodic Leg Movement Disorder - p. 127 22. Therapeutics for Parasomnias in Adults - p. 138 23. Therapeutics for Circadian Rhythm Sleep Disorders - p. 146 24. Index - p. 157
This issue comprises two parts. The first part examines pharmacology of drug classes and effects on the sleep--wake processes. The second part focuses on therapeutics for various sleep disorders. In the first part, basic neuropharmacology of sleep-wake states is discussed. Other articles review hypnotics, allergy and cardiovascular drugs, anti-convulsant drugs, anti-depressant and anti-psychotic drugs, and stimulants. The second part focuses on pharmacology for specific sleep disorders: primary insomnia, co-morbid insomnia, sleep-related breathing disorders, narcolepsy and disorders of daytime sleepiness, movement disroders, parasomnias, and circadian rhythm disorders.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. CME Accreditation Page and Author Disclosure - p. 4 5. Forthcoming Issues - p. 5 6. Contributors - p. 6 7. Foreword - p. 7 8. Preface - p. 8 9. Part I: The Pharmacology of Drug Classes and Effects on Sleep-Wake Processes - p. 9 10. Neuropharmacology of Sleep and Wakefulness - p. 10 11. Pharmacotherapy for Insomnia - p. 24 12. Allergy/Respiratory and Cardiovascular Drugs - p. 34 13. Drug-Related Sleep Stage Changes: Functional Significance and Clinical Relevance - p. 41 14. Antidepressant and Antipsychotic Drugs - p. 47 15. Stimulants in Excessive Daytime Sleepiness - p. 62 16. Part II: Therapeutics for Various Sleep Disorders - p. 74 17. Pharmacologic Treatment of Primary Insomnia - p. 75 18. Comorbid Insomnia: Reciprocal Relationships and Medication Management - p. 90 19. Therapeutics for Sleep-disordered Breathing - p. 105 20. Therapeutics of Narcolepsy - p. 115 21. The Pharmacologic Management of Restless Legs Syndrome and Periodic Leg Movement Disorder - p. 127 22. Therapeutics for Parasomnias in Adults - p. 138 23. Therapeutics for Circadian Rhythm Sleep Disorders - p. 146 24. Index - p. 157
